The Silent Epidemic of Survivorship: Rethinking Cardiovascular Risk in the Era of Targeted and Immune Cancer Therapies
David Bakunzi Barere, Ssempebwa Kato Daniel & Wanjala Micheal Junior · International Research Journal of Oncology · 2026
Background: Modern targeted and immune cancer therapies have shifted cardiotoxicity from acute myocardial damage to a chronic, multifaceted cardiovascular risk involving vascular, metabolic, and immune-mediated mechanisms. Aim: To delineate the emerging triad of chronic cardiovas...
Open access
Research Article
10.9734/irjo/2026/v9i1205